290 related articles for article (PubMed ID: 25851535)
1. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy.
Li C; Li W; Xiao J; Jiao S; Teng F; Xue S; Zhang C; Sheng C; Leng Q; Rudd CE; Wei B; Wang H
EMBO Mol Med; 2015 Jun; 7(6):754-69. PubMed ID: 25851535
[TBL] [Abstract][Full Text] [Related]
2. The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1.
Kliche S; Breitling D; Togni M; Pusch R; Heuer K; Wang X; Freund C; Kasirer-Friede A; Menasche G; Koretzky GA; Schraven B
Mol Cell Biol; 2006 Oct; 26(19):7130-44. PubMed ID: 16980616
[TBL] [Abstract][Full Text] [Related]
3. The pleckstrin homology domain in the SKAP55 adapter protein defines the ability of the adapter protein ADAP to regulate integrin function and NF-kappaB activation.
Burbach BJ; Srivastava R; Ingram MA; Mitchell JS; Shimizu Y
J Immunol; 2011 Jun; 186(11):6227-37. PubMed ID: 21525391
[TBL] [Abstract][Full Text] [Related]
4. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.
Taylor A; Harker JA; Chanthong K; Stevenson PG; Zuniga EI; Rudd CE
Immunity; 2016 Feb; 44(2):274-86. PubMed ID: 26885856
[TBL] [Abstract][Full Text] [Related]
5. CCR7-mediated LFA-1 functions in T cells are regulated by 2 independent ADAP/SKAP55 modules.
Kliche S; Worbs T; Wang X; Degen J; Patzak I; Meineke B; Togni M; Moser M; Reinhold A; Kiefer F; Freund C; Förster R; Schraven B
Blood; 2012 Jan; 119(3):777-85. PubMed ID: 22117043
[TBL] [Abstract][Full Text] [Related]
6. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.
Moran AE; Polesso F; Weinberg AD
J Immunol; 2016 Sep; 197(6):2509-21. PubMed ID: 27503208
[TBL] [Abstract][Full Text] [Related]
8. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
9. Distinct regulation of integrin-dependent T cell conjugate formation and NF-kappa B activation by the adapter protein ADAP.
Burbach BJ; Srivastava R; Medeiros RB; O'Gorman WE; Peterson EJ; Shimizu Y
J Immunol; 2008 Oct; 181(7):4840-51. PubMed ID: 18802088
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of ADAP/Fyb/SLAP-130 destabilizes SKAP55 in Jurkat T cells.
Huang Y; Norton DD; Precht P; Martindale JL; Burkhardt JK; Wange RL
J Biol Chem; 2005 Jun; 280(25):23576-83. PubMed ID: 15849195
[TBL] [Abstract][Full Text] [Related]
11. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.
Celus W; Oliveira AI; Rivis S; Van Acker HH; Landeloos E; Serneels J; Cafarello ST; Van Herck Y; Mastrantonio R; Köhler A; Garg AD; Flamand V; Tamagnone L; Marine JC; Di Matteo M; Costa BM; Bechter O; Mazzone M
Cancer Immunol Res; 2022 Jan; 10(1):126-141. PubMed ID: 34815265
[TBL] [Abstract][Full Text] [Related]
12. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas.
Li Z; Liu X; Guo R; Wang P
Tumour Biol; 2017 May; 39(5):1010428317698352. PubMed ID: 28475007
[TBL] [Abstract][Full Text] [Related]
13. Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression.
Wang Y; Sun SN; Liu Q; Yu YY; Guo J; Wang K; Xing BC; Zheng QF; Campa MJ; Patz EF; Li SY; He YW
Cancer Discov; 2016 Sep; 6(9):1022-35. PubMed ID: 27297552
[TBL] [Abstract][Full Text] [Related]
14. ADAP deficiency combined with costimulation blockade synergistically protects intestinal allografts.
Tian J; Rodriguez-Barbosa JI; Pabst O; Roemermann D; Foerster R; Beckmann J; Hoffmann MW
Transpl Int; 2010 Jan; 23(1):71-9. PubMed ID: 19678902
[TBL] [Abstract][Full Text] [Related]
15. Soluble γc receptor attenuates anti-tumor responses of CD8
Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
[TBL] [Abstract][Full Text] [Related]
16. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
17. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
18. Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
Zhang W; Shi L; Zhao Z; Du P; Ye X; Li D; Cai Z; Han J; Cai J
Cancer Chemother Pharmacol; 2019 May; 83(5):911-920. PubMed ID: 30848330
[TBL] [Abstract][Full Text] [Related]
19. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
20. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.
Leclerc M; Voilin E; Gros G; Corgnac S; de Montpréville V; Validire P; Bismuth G; Mami-Chouaib F
Nat Commun; 2019 Jul; 10(1):3345. PubMed ID: 31350404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
